On the Therapy for Polycystic Ovary Syndrome
Sir, We have read with great attention the article titled, "The inositols and polycystic ovary syndrome" by Kalra et al. [1] The authors have correctly outlined the physiological activities of the two most important stereoisomers of inositol, myoinositol (MI), and D-chiro-inositol (DCI). We provide a more accurate analysis of these data, which will help ensure pragmatic prescription of these useful molecules.
Kalra et al. stated, "the correction of systemic insulin resistance by MI will treat the metabolic features of polycystic ovary syndrome (PCOS). Simultaneously, adequate DCI levels will create a healthy intraovarian milieu, which will correct hyperandrogenism, improve menstrual regularity, and promote ovulation and fertility. …While MI is necessary for metabolic management, DCI is equally important for menstrual, ovulatory, and cutaneous hyperandrogenic resolution. …A high concentration of DCI is necessary to circumvent epimerase deficiency and ensure adequate levels in the ovary. Most pharmaceutical preparations provide very low amounts of DCI which are insufficient to achieve adequate levels in the ovary. Hence, formulations with relatively higher levels of DCI are preferred."
Recent scientific data, however, suggest otherwise. [2, 3] Of the two stereoisomers, MI stands out for its important biological roles as a leading molecule, whereas different integrative functions are carried out by DCI. In particular, whereas the activation of glucose transporters and glucose utilization take place under the regulation of MI, glycogen synthesis is mainly controlled through DCI. On the other hand, in the ovary, MI regulates glucose uptake and follicle-stimulating hormone (FSH) signaling, while DCI modulates insulin-induced androgen synthesis. [2, 3] In physiological conditions, the intracellular pool of inositol in human ovaries contains 99% of MI, whereas the remaining part is DCI. [4] In the ovary of PCOS women, we find an imbalance between MI and DCI concentrations, with a putative MI deficiency, which might impair the FSH signaling. [4] In these conditions, glucose uptake and metabolism of both oocytes and follicular cells are negatively affected compromising oocyte quality that depends on MI levels. [3] The improvement of ovarian function, as well as hormonal and metabolic parameters, was demonstrated after MI treatment in PCOS women. [5] Moreover, comparing the effects of metformin and MI on restored spontaneous ovulation activity in PCOS patients, the treated group showed better results for healed patients' number and recovery time. [3] Finally, high doses of DCI alone, administered to PCOS subjects, were found significantly detrimental for oocytes and therefore for fertility. [3] Sir, We read with interest the original article by Palaniappan et al. on iodine excess and Hashimoto's thyroiditis in children in which authors have reported a possible link between excess iodine intake by children and increasing the prevalence of autoimmune thyroiditis and eventually thyroid hypofunction. [1] In this regard, we would like to highlight recently published data on iodine status in several studies carried out in our country highlighting that iodine deficiency still continues to be endemic throughout India. [2, 3] In the state of Tamil Nadu, the overall utility of iodine-rich salt among households and 6-12 years children has been extensively evaluated by Pandav et al. with estimations of urinary iodine excretion (UIE) and goiter indices, respectively. His study among school children aged between 6 and 12 years age has reported consumption of iodized salt at 18%, total goiter index of 13.5%, median UIE <100 mcg/L in 56%, and below 50 mcg/L in 22% of the children. [4] As most reference ranges of TSH, free T4 and UIE levels are strongly determined by diurnal and circadian variations, quality control standards for all biological samples in particular for UIE status become important. Several studies carried out in state of Tamil Nadu and Chhattisgarh have utilized stringent external and internal quality standards greatly adding to the quality of data presented. [5] By not including iodine deficient children and the prevalence of autoimmune thyroid disease in the iodine deficient cohort, it is difficult to accept a causal link between the iodine excess and autoimmune thyroid disease. We would also like to know about the laboratory details where the urine iodine was performed and standardization procedure undertaken in this aspect. The mean and standard deviation of the urine iodine excretion between the two groups are presented with a P value, but the confidence intervals of UIE between the two groups could better highlight the overlap.
